Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study

JCE Lane, J Weaver, K Kostka, T Duarte-Salles, MTF Abrahao, H Alghoul, O Alser, TM Alshammari, P Biedermann, JM Banda, E Burn, P Casajust, MM Conover, AC Culhane, A Davydov, SL DuVall, D Dymshyts, S Fernandez-Bertolin, K Fister, J HardinL Hester, G Hripcsak, BS Kaas-Hansen, S Kent, S Khosla, S Kolovos, CG Lambert, Johan Lei, KE Lynch, R Makadia, AV Margulis, ME Matheny, P Mehta, DR Morales, H Morgan-Stewart, BMT (Mees) Mosseveld, D Newby, F Nyberg, A Ostropolets, RW Park, A Prats-Uribe, GA Rao, C Reich, J Reps, Peter Rijnbeek, SMK Sathappan, Martijn Schuemie, S Seager, AG Sena, A Shoaibi, M Spotnitz, MA Suchard, CO Torre, D Vizcaya, HN Wen, M (Marcel) de Wilde, JQ Xie, SC You, Lin Zhang, O Zhuk, P Ryan, D Prieto-Alhambra

Research output: Contribution to journalArticleAcademicpeer-review

61 Citations (Scopus)
1 Downloads (Pure)
Original languageEnglish
Pages (from-to)E698-E711
JournalThe Lancet Rheumatology
Volume2
Issue number11
DOIs
Publication statusPublished - 2020

Cite this